Comparing Eyetuck To Surgery Is More Than Mere Puffery – NAD
This article was originally published in The Rose Sheet
Executive Summary
Skin Doctors Cosmeceuticals should "limit its performance claims to the efficacy of the ingredient Eyeseryl" when touting its Eyetuck Anti-Bag Technology product for potential reduction of under eye puffiness, the National Advertising Division (NAD) concludes in an upcoming Case Reports
You may also be interested in...
NAD Finds Wrinkle In University Medical Advertising For Botox Alternative
The National Advertising Division recommends in a May 15 report that University Medical Pharmaceuticals modify print advertising claims promoting its WrinkleFree At Home Wrinkle Reversal System as a replacement for Botox and Restylane
NAD Finds Wrinkle In University Medical Advertising For Botox Alternative
The National Advertising Division recommends in a May 15 report that University Medical Pharmaceuticals modify print advertising claims promoting its WrinkleFree At Home Wrinkle Reversal System as a replacement for Botox and Restylane
NAD Remains On The Lookout For Performance Claims That Exceed Puffery
The National Advertising Division of the Council of Better Business Bureaus will continue to watch for quantified and comparison-based performance claims within the increasingly sophisticated cosmetics marketplace, according to Director Andrea Levine